Long-term regulation of synapsin I gene expression and neuronal morphology by cyclic AMP and low-dose staurosporine

Molecular Brain Research

Volumn 40, Issue 1, 1996, Pages 157-160

  Sasaki, Kazuki ^a   Tsukada, Toshihiko ^a   Maruyama, Kouji ^a   Yamaguchi, Ken ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Cyclic AMP; Dopamine hydroxylase; Gene expression; Neuroblastoma; Staurosporine; Synapsin I

Indexed keywords

CYCLIC AMP; DOPAMINE BETA MONOOXYGENASE; STAUROSPORINE; SYNAPSIN I;

ANTIGEN EXPRESSION; ARTICLE; CELL STRUCTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NEURITE; NEUROBLASTOMA; NEUROBLASTOMA CELL; PHENOTYPE; PRIORITY JOURNAL;

EID: 0030221704     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(96)00093-9     Document Type: Article

References (23)

1. [1] Cauvin, A., Buscail, L., Gourlet, P., Woussen-Colle, M.C., Robberecht, P., De Neef, P., Gossen, D., Arimura, A., Miyata, A., Coy, D.H., Robberecht, P. and Christophe, J., The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK, Peptides, 11 (1990) 773-777.
2. [2] Glicksman, M.A., Prantner, J.E., Meyer, S.L., Forbes, M.E., Dasgupta, M., Lewis, M.E. and Neff, N., K-252a and staurosporine promote choline acetyltransferase activity in rat spinal cord cultures, J. Neurochem., 61 (1993) 210-221.
3. [3] Goodman, R.H., Regulation of neuropeptide gene expression, Annu. Rev. Neurosci., 13 (1990) 111-127.
4. [4] Greengard, P., Valtorta, F., Czernik, A.J. and Benfenati, F., Synaptic vesicle phosphoproteins and regulation of synaptic function, Science, 259 (1993) 780-785.
5. [5] Hösche, C., Bartsch, P. and Kilimann, M.W., The CRE consensus sequence in the synapsin I gene promoter region confers constitutive activation but no regulation by cAMP in neuroblastoma cells, Biochim. Biophys. Acta, 1261 (1995) 249-256.
6. [6] Jalava, A., Åkerman, K. and Heikkila, J., Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an α-, γ-, and ζ-protein kinase C-independent pathway, J. Cell Physiol., 55 (1993) 301-312.
7. [7] Jüngling, S., Cibelli, G., Czardybon, M., Gerdes, H.H. and Thiel, G., Differential regulation of chromogranin B and synapsin I gene promoter activity by cAMP and cAMP-dependent protein kinase, Eur. J. Biochem., 226 (1994) 925-935.
8. [8] Lamouroux, A., Vigny, A., Faucon Biguet, N., Darmon, M.C., Franck, R., Henry, J.P. and Mallet, J., The primary structure of human dopamine-β-hydroxylase: insights into the relationship between the soluble and the membrane-bound forms of the enzyme, EMBO J., 6 (1987) 3931-3937.
9. [9] LoPresti, P., Poluha, W., Poluha, D.K., Drinkwater, E. and Ross, A.H., Neuronal differentiation triggered by blocking cell proliferation. Cell Growth Diff., 3 (1992) 627-635.
10. [10] Morioka, H., Ishihara, M., Shibai, H. and Suzuki, T., Staurosporine induced differentiation in a human neuroblastoma cell line, NB-1, Agric. Biol. Chem., 49 (1985) 1959-1963.
11. [11] Nabeshima, T., Ogawa, T., Nishimura, H., Fuji, K., Kameyama, T. and Sasaki, Y., Staurosporine facilitates recovery from the basal forebrain-lesion-induced impairment of learning and deficit of cholinergic neuron in rats, J. Pharmacol. Exp. Ther., 257 (1991) 562-566.
12. [12] Nirenberg, M., Wilson, S., Higashida, H., Rotter, A., Krueger, K., Busis, N., Ray, R., Kenimer, J.G. and Adler, M., Modulation of synapse formation by cyclic adenosine monophosphate, Science, 222 (1983) 794-798.
13. [13] Omura, S., Iwai, Y., Hirano, A., Nakagawa, A., Awaya, J., Tsuchiya, H., Takahashi, Y. and Masuma, R., A new alkaloid AM-2282 of Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization, J. Antibiot., 30 (1977) 275-281.
14. [14] Ponte, P., Ng, Sun-Yu, Engel, J., Gunning, P. and Kedes, L., Evolutionary conservation in the untranslated regions of actin mR-NAs: DNA sequence of a human beta-actin cDNA, Nucleic Acids Res., 12 (1984) 1687-1696.
15. [15] Rasouly, D., Rahamim, E., Lester, D., Matsuda, Y. and Lazarovici, P., Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition, Mol. Pharmacol., 42 (1992) 35-43.
16. [16] Rydel, R. and Greene, L.A., cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor, Proc. Natl. Acad. Sci. USA. 85 (1988) 1257-1261.
17. [17] Sasaki, K., Adachi, I., Yanaihara, N. and Yamaguchi, K., Neuronal cell differentiation of human neuroblastoma NB-OK-1 cells by staurosporine plus pituitary adenylate cyclase-activating peptide-38, Biomed. Res., 15 (Suppl. 2) (1994) 247-252.
18. [18] Sasaki, K., Tsukada, T., Adachi, I. and Yamaguchi, K., Staurosporine potentiates cAMP-mediated promoter activity of the vasoactive intestinal polypeptide gene in rat pheochromocytoma PC12 cells, Biochem. Biophys. Res. Commun., 214 (1995) 1114-1120.
19. [19] Slack, R.S. and Proulx, P., Effects of retinoic acid and staurosporine on the protein kinase C activity and the morphology of two related human neuroblastoma cell lines, Biochim. Biophys. Acta, 1053 (1990) 89-96.
20. [20] Südhof, T.C., The structure of the human synapsin I gene and protein, J. Biol. Chem., 265 (1990) 7849-7852.
21. [21] Tamaoki, T., Use and specificity of staurosporine, UCN-01, and calphostin C as protein kinase inhibitors, Methods Enzymol., 201 (1991) 340-347
22. [22] Thiel, G., Greengard, P. and Südhof, T.C., Characterization of tissue-specific transcription by the human synapsin I gene promoter, Proc. Natl. Acad. Sci. USA, 85 (1991) 3431-3435.
23. [23] Tsukada, T., Fink, J.S., Mandel, G. and Goodman, R.H., Identification of a region in the human vasoactive intestinal polypeptide gene responsible for regulation by cyclic AMP, J. Biol. Chem., 262 (1987) 8743-8747.